Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Optic provides an AI-native platform that automates evaluation, discovery, and prioritization of drug candidates to accelerate pharmaceutical R&D. It combines generative and agentic AI with…

Optic provides an AI-native platform that automates evaluation, discovery, and prioritization of drug candidates to accelerate pharmaceutical R&D. It combines generative and agentic AI with…
What they do: AI-native drug discovery platform that automates evaluation, discovery, and prioritization of drug candidates
Founded / HQ: Founded 2020 or 2021; headquartered in San Francisco, California
Tech: Generative and agentic AI, ligand- and structure-based molecular models, LLM-driven workflows; GPU-accelerated SaaS
Recent funding: Seed round closed Jul 20, 2022; lead investors include Kleiner Perkins and Pantera Capital
Preclinical drug discovery and business diligence for biopharma and biotech teams.
2021
Biotechnology
Seed round closed Jul 20, 2022; Crunchbase lists lead investors as Kleiner Perkins and Pantera Capital.
“Backed by multiple investors including Kleiner Perkins, Pantera Capital, Polygon, and BBQ Capital”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,300+
New This Week